CVE-2023-33365
A path traversal vulnerability exists in Suprema BioStar 2 before 2.9.1, which allows...
A path traversal vulnerability exists in Suprema BioStar 2 before 2.9.1, which allows unauthenticated attackers to fetch arbitrary files from the server's web server.
Attack profile
How easy it is to exploit
- Attack vector
- Network
- Complexity
- Low
- Privileges needed
- None
- User interaction
- None
What an attacker can affect
- Confidentiality
- High
- Integrity
- None
- Availability
- None
Exploit likelihood
What each source reports
NVD Score used
A path traversal vulnerability exists in Suprema BioStar 2 before 2.9.1, which allows unauthenticated attackers to fetch arbitrary files from the server's web server.
- Record
CVE-2023-33365- CVSS 3.1
- 7.5 High
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N - Weakness
- CWE-22
- Updated
- 2026-11-02
CVE List No score
A path traversal vulnerability exists in Suprema BioStar 2 before 2.9.1, which allows unauthenticated attackers to fetch arbitrary files from the server's web server.
- Record
CVE-2023-33365- Updated
- 2026-11-02
EUVDEUVD-2023-37528 No score
A path traversal vulnerability exists in Suprema BioStar 2 before 2.9.1, which allows unauthenticated attackers to fetch arbitrary files from the server's web server.
- Record
EUVD-2023-37528- Updated
- 2026-11-03
GitHub AdvisoriesGHSA-3xwr-xcmc-7vq6
A path traversal vulnerability exists in Suprema BioStar 2 before 2.9.1, which allows...
A path traversal vulnerability exists in Suprema BioStar 2 before 2.9.1, which allows unauthenticated attackers to fetch arbitrary files from the server's web server.
- Record
GHSA-3xwr-xcmc-7vq6- CVSS 3.1
- 7.5 High
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N - Weakness
- CWE-22
- Updated
- 2026-11-02
Affected products
History
| Recorded | Changed | Sources |
|---|---|---|
| aliases | EUVD | |
| first indexed | CVE List, GitHub Advisories, NVD |
Dates are when Every CVE recorded each change. Upstream dates may differ.
In short
CVE-2023-33365 is a high vulnerability (CVSS 7.5) in Supremainc Biostar 2, published August 3, 2023. No source lists public exploit code. EPSS puts the chance of exploitation in the next 30 days at 0.73%, the 54th percentile. No source names a fixed version.